SUO Clinical Trials Consortium
Business Services · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1933 N Meacham Rd Ste 450, Schaumburg, I...Phone Number
(847) 264-5901Website
www.suoctc.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About SUO Clinical Trials Consortium
The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) focuses on enhancing research options to improve the quality of life for patients with urologic cancers, including bladder cancer, prostate cancer, and renal cell carcinoma. With a network of over 250 sites in the U.S. and Canada, the consortium comprises more than 500 members dedicated to conducting clinical trials. SUO-CTC also emphasizes the importance of publishing research findings to advance scientific knowledge within the medical community. Their services include membership applications and calls for sites to participate in ongoing clinical trials.Explore more
Popular SearchesSUO Clinical Trials ConsortiumClinical Trials ConsortiumSociety of Urologic Oncology Clinical Trials Conso...Urologic Oncology Clinical Trials ConsortiumSIC Code 87,873NAICS Code 54,541Show moreSUO Clinical Trials Consortium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SUO Clinical Trials Consortium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when SUO Clinical Trials Consortium launches new products
Funding: Get notified immidiatlly once SUO Clinical Trials Consortium has new funding data
Earning: See what the market has to say on SUO Clinical Trials Consortium recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if SUO Clinical Trials Consortium had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if SUO Clinical Trials Consortium has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at SUO Clinical Trials Consortium
SUO Clinical Trials Consortium, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if SUO Clinical Trials Consortium is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined SUO Clinical Trials Consortium as Masked Content
Find 2 more new buyers
Compare Similar Companies to SUO Clinical Trials Consortium
Compare insights from companies similar to SUO Clinical Trials Consortium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SUO Clinical Trials Conso...
<$5M
11-50
Private
-
-
PM
Pamela MurphyExecutive Director, Clinical Research Services
Company Profile Activity
Activity Insights
SUO Clinical Trials Consortium is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SUO Clinical Trials Consortium is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SUO Clinical Trials Consortium.
SUO Clinical Trials Consortium Tech Stack
SUO Clinical Trials Consortium News & Media
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and community based uro-oncologists, and CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced the second annual CG-SUO-CTC NMIBC Research FellowshipSUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardSUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardAngioDynamics Completes Enrollment for PRESERVE Clinical Study
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced the completion of enrollment and final treatment in its Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population (PRESERVE). The PRESERVE study was initia
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SUO Clinical Trials Consortium
Sign Up For FreeTo access detailed company insights
The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) focuses on enhancing research options to improve the quality of life for patients with urologic cancers, including bladder cancer, prostate cancer, and renal cell carcinoma. With a network of over 250 sites in the U.S. and Canada, the consortium comprises more than 500 members de... Read More
